Essex LLC Merck & Co., Inc. Transaction History

Essex LLC

$482 Million
Q3 2024

A detailed history of Essex LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Essex LLC holds 34,002 shares of MRK stock, worth $3.33 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

34,002

Previous 35,661 4.65%

Holding current value

$3.33 Million

Previous $4.41 Million 12.53%

% of portfolio

0.8%

Previous 1.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$111.15 - $128.97 $184,397 - $213,961	-1,659 Reduced 4.65%	34,002 $3.86 Million
Q2 2024 Jul 22, 2024	SELL	$123.8 - $132.96 $28,969 - $31,112	-234 Reduced 0.65%	35,661 $4.41 Million
Q1 2024 May 03, 2024	SELL	$113.24 - $131.95 $53,789 - $62,676	-475 Reduced 1.31%	35,895 $4.74 Million
Q4 2023 Jan 29, 2024	BUY	$100.18 - $109.02 $346,021 - $376,555	3,454 Added 10.49%	36,370 $3.97 Million
Q3 2023 Oct 16, 2023	BUY	$102.95 - $114.33 $219,489 - $243,751	2,132 Added 6.93%	32,916 $3.39 Million
Q2 2023 Jul 31, 2023	SELL	$108.61 - $118.38 $80,154 - $87,364	-738 Reduced 2.34%	30,784 $3.55 Million
Q4 2022 Jan 30, 2023	SELL	$87.44 - $112.11 $29,117 - $37,332	-333 Reduced 1.05%	31,522 $3.5 Million
Q3 2022 Nov 07, 2022	SELL	$84.53 - $94.96 $55,282 - $62,103	-654 Reduced 2.01%	31,855 $2.74 Million
Q2 2022 Aug 01, 2022	BUY	$83.49 - $94.64 $40,242 - $45,616	482 Added 1.5%	32,509 $2.96 Million
Q1 2022 Apr 20, 2022	BUY	$73.51 - $82.4 $229,792 - $257,582	3,126 Added 10.82%	32,027 $2.63 Million
Q4 2021 Jan 28, 2022	BUY	$72.28 - $90.54 $136,970 - $171,573	1,895 Added 7.02%	28,901 $2.22 Million
Q3 2021 Oct 21, 2021	BUY	$71.68 - $78.83 $1.94 Million - $2.13 Million	27,006 New	27,006 $2.03 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex LLC with notifications on news.

Account